Cost-effectiveness analysis of abrocitinib compared with other systemic treatments for severe atopic dermatitis in Spain
Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by itchy, painful, and dry skin. Despite the great number of available therapies, economic evaluations are needed to provide evidence on their cost-efficiency to assist the National Health System (NHS) in decision-making. The objective of this study is to evaluate the cost-effectiveness of abrocitinib (200mg) […]
Pharmacoeconomic Analysis Of Abrocitinib In Patients With Severe Atopic Dermatitis Versus Systemic Treatments In Spain
Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by itchy, painful, and dry skin. Despite the great number of available therapies, economic evaluations are needed to provide evidence on their cost-efficiency to assist the National Health System (NHS) in decision-making. The objective of this study is to evaluate the cost-effectiveness of abrocitinib (200mg) […]
Assessing the value of atopic dermatitis treatment using Multi-Criteria Decision Analysis (MCDA)
MCDA to create an optimal conceptual framework for evaluating novel treatments in moderate-to-severe AD by establishing the most relevant health outcomes (criteria) for decision-making from all stakeholders’ perspectives (patients, clinicians and payers).
Iniciativa estratégica de salud vida fase 2: “Estrategias para la mejora en la atención a pacientes con dermatitis atópica de moderada a grave
It has defined strategies to optimise the management of patients with moderate-severe AD, covering previously identified critical needs.
Acuerdo de riesgo compartido en el tratamiento con certolizumab pegol en pacientes adultos con psoriasis moderada-grave: datos en PRÁCTICA CLÍNICA real
Estimation of avoidable costs in the care process of axial spondyloarthritis and psoriatic arthritis, based on possible improvements of inefficiencies in the current care process.
La nueva Dermalidad. Conocer el modelo asistencial de la psoriasis para avanzar en su abordaje.
Identification and prioritisation of current challenges and needs in the management of patients with psoriasis.
Patient-Reported Outcome Measures in Real-World Atopic Dermatitis Studies inSpain: A Systematic Review
Identification and description of patient-reported outcome measures (PROM) used in observational studies of atopic dermatitis over the last decade in Spain.
Iniciativa estratégica de salud ViDA: Vivir con Dermatitis Atópica
Top 10 unmet priority needs in the management of patients with severe AD from the perspective of healthcare professionals and patients.
Carga de la psoriasis en Cataluña: datos epidemiológicos, comorbilidades asociadas, uso de recursos sanitarios e incapacidad laboral
Estimation of the epidemiologic burden of psoriasis and evaluation of the associated comorbidities, health care utilization, and sick leave, based on data from the 2016 Catalan Health Survey, the Catalan Registry of Morbidity and Utilization of Health Care Services (2016), and the database of the Catalan Medical Evaluations Institute (2012—2016).
Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature
